DSM-Firmenich AG (WBO:DSFI) FFO


WBO:DSFI DSM-Firmenich AG WBO:DSFI
35 GF Score
Price €86.14
GF Value €76.36
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is DSM-Firmenich AG FFO?

FFO (Funds from operations) only applies to REITs.

WBO:DSFI
35GF Score
DSM-Firmenich AG WBO:DSFI
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DSM-Firmenich AG (WBO:DSFI) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of €86.14 is trading 12.8% above its estimated GF Value™ of €76.36. GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.

Key valuation signals for WBO:DSFI:

  • FFO:
  • GF Value™: €76.36 vs. price of €86.14 (12.8% above fair value)
  • GF Score™: 35/100 with 8 warning signs

No single metric tells the full story. See the WBO:DSFI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
35GF Score

Get the complete analysis for WBO:DSFI

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€86.14
Price
€76.36
GF Value